0
BridgeBio Pharma, Inc. Banner Image

BridgeBio Pharma, Inc. has reached its limit for free report views

Work for BridgeBio Pharma, Inc.? Upgrade Your Profile and unlock all your responsibility reports.

BridgeBio Pharma, Inc.

  • Ticker BBIO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
BridgeBio Pharma, Inc. Logo Image
  • 201-500 Employees
  • Based in Palo Alto, California
BridgeBio is a team of experienced drug discoverers, developers and innovators working to create life-altering medicines that target well-characterized genetic diseases at their source. BridgeBio was founded in 2015 to identify and advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancersMore with clear genetic drivers. BridgeBio’s pipeline of over 20 development programs includes product candidates ranging from early discovery to late-stage development.
BridgeBio Pharma, Inc.

Most Recent Responsibility Report

BridgeBio Pharma, Inc.
MOST RECENT 2022 Environmental, Social, and Governance Report

Report Locked. BridgeBio Pharma, Inc. has reached its limit for free report views.

BridgeBio Pharma, Inc. does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Archived Responsibility Reports

Our service enables potential investors to review the most recent and archived BridgeBio Pharma, Inc. Sustainability Report, BridgeBio Pharma, Inc. Corporate Social Responsibility Report, BridgeBio Pharma, Inc. CSR Report, BridgeBio Pharma, Inc. Corporate Responsibility, BridgeBio Pharma, Inc. CR Report, BridgeBio Pharma, Inc. Citizenship Report, BridgeBio Pharma, Inc. ESG Report, and BridgeBio Pharma, Inc. Environmental Report online.
BridgeBio Pharma, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!